(Q88973803)

6

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

27 May 2020

author name string

Junsong Zhang

1

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

27 May 2020

Xiancai Ma

2

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

27 May 2020

Fei Yu

3

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

27 May 2020

Jun Liu

4

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

27 May 2020

Fan Zou

5

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

27 May 2020

Hui Zhang

7

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

Origin and evolution of pathogenic coronaviruses

27 May 2020

language of work or name

English

0 references

publication date

13 February 2020

0 references

published in

bioRxiv

0 references

cites work

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Coronaviruses: genome structure, replication, and pathogenesis

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Interspecies transmission and emergence of novel viruses: lessons from bats and birds

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Bat-to-human: spike features determining 'host jump' of coronaviruses SARS-CoV, MERS-CoV, and beyond

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

SARS and MERS: recent insights into emerging coronaviruses

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

The severe acute respiratory syndrome

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Coronavirus as a possible cause of severe acute respiratory syndrome

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Offline: 2019-nCoV outbreak-early lessons

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

A Novel Coronavirus from Patients with Pneumonia in China, 2019

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

A new coronavirus associated with human respiratory disease in China

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

A pneumonia outbreak associated with a new coronavirus of probable bat origin

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Coronavirus spike proteins in viral entry and pathogenesis

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

A transmembrane serine protease is linked to the severe acute respiratory syndrome coronavirus receptor and activates virus entry

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Different residues in the SARS-CoV spike protein determine cleavage and activation by the host cell protease TMPRSS2.

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV).

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

MEGA X: Molecular Evolutionary Genetics Analysis across Computing Platforms

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

WebLogo: A Sequence Logo Generator

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Proteolytic activation of the SARS-coronavirus spike protein: cutting enzymes at the cutting edge of antiviral research.

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Mechanisms of coronavirus cell entry mediated by the viral spike protein

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

The novel coronavirus 2019 (2019-nCoV) uses the SARS-coronavirus receptor ACE2 and the cellular protease TMPRSS2 for entry into target cells

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Teichomycins, new antibiotics from Actinoplanes teichomyceticus nov. sp. IV. Separation and characterization of the components of teichomycin (teicoplanin)

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

27 May 2021

1 reference

https://api.crossref.org/works/10.1101/2020.02.05.935387

Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties

27 May 2021

0 references

Identifiers

1 reference

https://api.crossref.org/v1/works/http://dx.doi.org/10.1101/2020.02.05.935387

Dimensions Publication ID

27 May 2020

1124849056

1 reference

Dimensions COVID-19 publications, datasets and clinical trials

10.6084/M9.FIGSHARE.11961063